-
German working-age population to shrink dramatically: study
-
MSF warns of 'dangerous gaps' in Ebola response in DR Congo
-
Three things we learned from the Barcelona Grand Prix
-
Deadly Russian strikes leave landmark Kyiv cathedral in flames
-
Real Madrid confirm Cucurella signing from Chelsea
-
At least 2,300 killed this year in Haiti gang violence: UN
-
EU moves Ukraine's membership bid forward, but long road ahead
-
G7 allies seek common ground with Trump after Iran accord
-
Hope for peace with North, but not unification at S. Korea festival
-
Iran take center stage at World Cup as Spain make bow
-
Kyrgyzstan bets on reality TV to tackle obesity crisis
-
Burnt-out Indonesians beat the blues with children's games
-
Greek fishermen struggle to keep up with pufferfish invaders
-
Blood sport at the White House for Trump's 80th birthday
-
Broeders-Bol backed by coach to challenge the very best over 800m
-
Sweden demolish Tunisia 5-1 to seize control of World Cup group
-
'For sure': Macron to preach stronger Europe vision at G7 swansong
-
France hosts G7 dominated by Trump, Iran
-
Carolina beat Vegas to end 20-year wait for second Stanley Cup
-
Middle East war: peace deal reactions
-
Crude prices plunge, stocks surge on US-Iran peace deal
-
Deadly strikes on Ukraine leave Kyiv cathedral in flames
-
Driven O'Brien looks to bring up ton at Ascot to ring in 30 years of glory
-
First major bump but prodigy Seixas still headed for the top
-
Starbucks Korea to shutter outlets for history lessons after 'Tank Day' fiasco
-
Diomande targets World Cup run as Ivory Coast win opener
-
EU moves Ukraine's membership bid forward, but tough road ahead
-
'This is our culture': Japan fans clean up World Cup stadium
-
Courts cracking down on error-strewn AI-assisted legal briefs
-
The Iranian leaders killed in Israeli-US war
-
UK PM promises 'bold action' on failing social media status quo
-
Ghalibaf: ambitious 'public face' of post-Ali Khamenei Iran
-
Trump turns 80 with cage fight, Iran deal
-
Musical therapy: Classical concerts in New York for dementia sufferers
-
Diallo strikes late as Ivory Coast stun Ecuador at World Cup
-
Bellingham can be England's World Cup 'X factor': Henderson
-
Iran World Cup coach says 'impacted' by politics but ignoring 'hype'
-
Cape Verde's Bubista relishing 'dream' World Cup clash with Spain
-
Instawork Posts Fifth Straight Month of Double-Digit Shift Growth; Platform Wages Up 6%
-
Trifecta Gold Announces Private Placements
-
Banyan Gold Commences Greenfields Diamond Drilling at Nitra Project, Yukon
-
FireFox Gold Closes First Tranche of Non-Brokered Private Placement
-
Eagle Plains' Partner Xcite Uranium Receives Permits and Commences Fieldwork at the Uranium City Project, Saskatchewan
-
BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF
-
Caledonia Mining Corporation Plc: Publication of 2025 ESG Report
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 15
-
Cauley wins Canadian Open eight years after crash derailed his PGA career
-
Davis-Woodhall doubles up at LA Grand Prix
-
Germany crush Curacao, Japan thwart Dutch at World Cup as Iran arrive
-
Curacao have nothing to be ashamed about, says Advocaat
Nitches, Inc. (OTC: NICH) Is Building the Checkpoint Every Supplement Brand Will Have to Pass Before It Spends a Dollar on Manufacturing
A new supplement readiness platform is coming. The company that formulated InTheZone is turning its capability outward, toward the founders, brands, and capital that need to know a product can survive scrutiny before the money moves.
LAS VEGAS, NV / ACCESS Newswire / June 11, 2026 / Nitches, Inc (OTCID:NICH) - Founders, creators, and brands interested in learning more about starting a supplement line can email [email protected] now for soft launch details and early access to the list.
Nitches, Inc. is preparing a new platform designed to help supplement founders and brands move from idea to product readiness with more clarity than the industry has ever offered them.
The thesis is direct. Most supplement ideas do not fail because the founder lacked ambition. They fail because the path from idea to formula, claims, label, manufacturing, packaging, and fulfillment is fragmented, and the costly surprises arrive after the capital is already committed. Nitches is building the checkpoint that comes before money moves.
What the Platform Does
The platform is being built to guide users through the early product-building process. It helps founders and brands:
Shape a supplement concept
Explore formulation direction
Review ingredient evidence
Understand claim and label readiness
Generate a product readiness score
Create a portable product record
Prepare for manufacturing review
Explore startup-friendly production pathways
Connect the idea-to-shelf process more intelligently
This is not just another supplement website. It is designed to become the checkpoint before money moves into manufacturing, branding, packaging, and launch.
The Foundation Beneath It
Nitches did not arrive at this from theory. The company formulated and brought to market InTheZone, and it is now turning that same capability into infrastructure for others.
The platform sits on top of real manufacturing readiness. Nitches works in alignment with an FDA-registered, cGMP-aligned manufacturing partner, a fully integrated producer of fine, all-natural nutraceuticals and engineered body-management products. The categories of demand are growing fast: everyday immune and metabolic wellness, and active lifestyle and sports-performance formulations.
Every product moves through a defined development process, from concept through formulation, claim and label review, product record, and manufacturing preparation. The intelligence the platform surfaces is the same discipline Nitches applies to its own products, now made portable for the founders it chooses to work with.
Why This Matters Now
Consumers are increasingly prioritizing health, wellness, fitness, and ingredient transparency. As demand grows for products supported by sound formulation, quality manufacturing, and credible product positioning, supplement founders face greater scrutiny than ever before. The brands that succeed are those that identify risks early and build with clarity from the start. Nitches is developing the infrastructure designed to help founders navigate that process before significant capital is committed.
Official platform details will be announced soon. Stay tuned to the company's social media channels.
Founders, creators, and brands interested in learning more during soft launch can email [email protected] for early details.
About Nitches, Inc.
Nitches, Inc. (OTC: NICH) is a supplement and lifestyle-enhancement company preparing a new product readiness platform that helps founders, brands, and manufacturing partners move from supplement idea to formula, score, product record, and manufacturing readiness.
Investor Relations
John Morgan
Nitches, Inc. (OTC: NICH)
[email protected]
+1 (678) 999-6242
NITCHES, INC.
1333 N Buffalo Dr. Suite 210
Las Vegas, NV 89128
+1 (678) 999-6242
[email protected]
Disclaimer: Platform outputs are informational and do not constitute legal, regulatory, medical, scientific, manufacturing, financial, or investment advice. Dietary supplement products are not FDA-approved. Statements regarding the platform reflect current plans and are subject to change.
Forward-Looking Statements
This communication may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations, estimates, and projections and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Nitches, Inc. undertakes no obligation to update or revise any forward-looking statements except as required by law.
SOURCE: Nitches, Inc.
View the original press release on ACCESS Newswire
Y.Baker--AT